arrow
A

Albert Muñoz-Vendrell

hospital universitari de bellvitge-idibell and universitat de barcelona
H指数:10
被引数:513

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evaluation of the effectiveness and safety of anti-CGRP monoclonal antibodies in patients with migraine and autoimmune diseases: IMMUNO-CGRP study

评估抗CGRP单克隆抗体在偏头痛和自身免疫性疾病患者中的有效性与安全性:IMMUNO-CGRP研究

IF0
2026-04-010
OAAI
Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response

阿托格匹兰坦在抗CGRP单克隆抗体治疗失败的偏头痛患者中的应用:一项关于疗效、安全性、持续性和应答预测因子的多中心真实世界研究

2025-11-280
OAAI
The 2024 McDonald criteria show comparable sensitivity to previous criteria for late-onset multiple sclerosis

2024年McDonald标准在晚期发病多发性硬化方面显示出与以往标准相当的敏感性。

2025-07-290
OAAI
Resistant and refractory migraine - two different entities with different comorbidities? Results from the REFINE study

耐药性和难治性偏头痛-具有不同合并症的两种不同实体?REFINE研究的结果

2024-12-030
OAAI
Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world
2024-05-2210
PRE
Effectiveness and safety of anti-CGRP monoclonal antibodies in patients over 65 years: a real-life multicentre analysis of 162 patients
2023-06-0220
OAAI